Given the substantial prevalence of heterozygous individuals for A-T, comprising about 2 % of the adult population [44], the findings of this study suggest that genetic analysis of ATM gene could be particularly valuable in subjects with atherosclerotic disease but without classic cardiovascular risk factors, or in cardiovascular diseases with unclear etiology, to implement patient-targeted prevention strategies. The gene discussed is ATM; the disease is cardiovascular disorder.